Employees Retirement System of Texas’s Bio-Rad Laboratories Class A BIO Stock Holding History

Employees Retirement System of Texas’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,500	Closed	-$2.23M	–	390
2022 Q2	$2.23M	Hold	4,500	–	–	0.03%	471
2022 Q1	$2.54M	Hold	4,500	–	–	0.03%	486
2021 Q4	$3.4M	Hold	4,500	–	–	0.04%	439
2021 Q3	$3.36M	Hold	4,500	–	–	0.04%	452
2021 Q2	$2.9M	Hold	4,500	–	–	0.04%	459
2021 Q1	$2.57M	Hold	4,500	–	–	0.03%	506
2020 Q4	$2.62M	Hold	4,500	–	–	0.04%	416
2020 Q3	$2.32M	Hold	4,500	–	–	0.03%	456
2020 Q2	$2.03M	Hold	4,500	–	–	0.03%	467
2020 Q1	$1.58M	Hold	4,500	–	–	0.03%	459
2019 Q4	$1.67M	Hold	4,500	–	–	0.03%	571
2019 Q3	$1.5M	Sell	4,500 -3,500	-44%	-$1.14M	0.02%	597
2019 Q2	$2.5M	Hold	8,000	–	–	0.04%	483
2019 Q1	$2.44M	Hold	8,000	–	–	0.04%	510
2018 Q4	$1.86M	Hold	8,000	–	–	0.03%	581
2018 Q3	$2.5M	Sell	8,000 -2,000	-20%	-$621K	0.03%	542
2018 Q2	$2.88M	Buy	10,000 +4,000	+67%	+$1.1M	0.04%	518
2018 Q1	$1.5M	Sell	6,000 -1,000	-14%	-$255K	0.02%	711
2017 Q4	$1.67M	Sell	7,000 -3,000	-30%	-$727K	0.02%	685
2017 Q3	$2.22M	Hold	10,000	–	–	0.03%	605
2017 Q2	$2.26M	Sell	10,000 -8,000	-44%	-$1.74M	0.03%	600
2017 Q1	$3.59M	Hold	18,000	–	–	0.05%	470
2016 Q4	$3.28M	Buy	+18,000	New	+$3.07M	0.04%	475
2015 Q1	–	Sell	-15,000	Closed	-$1.81M	–	959
2014 Q4	$1.81M	Buy	+15,000	New	+$1.73M	0.02%	646
2014 Q1	–	Sell	-26,000	Closed	-$3.21M	–	981
2013 Q4	$3.21M	Hold	26,000	–	–	0.04%	470
2013 Q3	$3.06M	Hold	26,000	–	–	0.04%	462
2013 Q2	$2.92M	Buy	+26,000	New	+$3.05M	0.03%	477

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Employees Retirement System of Texas's BIO Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 4,500 shares — an estimated $2.23M sold.

Employees Retirement System of Texas first reported a position in BIO in Q2 2013 and held it in 27 quarters. The position peaked at $3.59M in Q1 2017. 486 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Employees Retirement System of Texas reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Employees Retirement System of Texas sold 4,500 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $2.23M.
Employees Retirement System of Texas first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 27 quarters.
Employees Retirement System of Texas's Bio-Rad Laboratories Class A position peaked at $3.59M in Q1 2017.
486 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.